CU20060213A7 - AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITION - Google Patents
AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- CU20060213A7 CU20060213A7 CU20060213A CU20060213A CU20060213A7 CU 20060213 A7 CU20060213 A7 CU 20060213A7 CU 20060213 A CU20060213 A CU 20060213A CU 20060213 A CU20060213 A CU 20060213A CU 20060213 A7 CU20060213 A7 CU 20060213A7
- Authority
- CU
- Cuba
- Prior art keywords
- antimicobacterial
- pharmaceutical composition
- methyl
- formula
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se decriben una combinación antimicobacteriana y una composición para tratar tuberculosis. Los compuestos usados son N-(3-[[4-trifluorometilfenil)piperazinil] metil]-2-metil-5-fenil-pirrolil) -4- piridilcarboxalamida de la fórmula (I) o su sal no tóxica farmacéuticamente aceptable (ESPACIO PARA FÓRMULA) y una cantidad de uno o más fármacos antituberculosos de primera línea.An antimicobacterial combination and a composition for treating tuberculosis are described. The compounds used are N- (3 - [[4-trifluoromethylphenyl) piperazinyl] methyl] -2-methyl-5-phenyl-pyrrolyl) -4-pyridylcarboxalamide of the formula (I) or its non-toxic pharmaceutically acceptable salt (SPACE FOR FORMULA) and an amount of one or more first-line antituberculosis drugs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060213A CU20060213A7 (en) | 2006-11-07 | 2006-11-07 | AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060213A CU20060213A7 (en) | 2006-11-07 | 2006-11-07 | AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20060213A7 true CU20060213A7 (en) | 2009-09-08 |
Family
ID=44280810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20060213A CU20060213A7 (en) | 2006-11-07 | 2006-11-07 | AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITION |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20060213A7 (en) |
-
2006
- 2006-11-07 CU CU20060213A patent/CU20060213A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066950A (en) | ADRENOCEPTOR-BETA2 GLICOPIRROLATE AND AGONIST COMBINATIONS | |
| HUS1600021I1 (en) | MEK inhibitors and methods for their use | |
| CY1117978T1 (en) | THERAPEUTIC USES OF COMPOUNDS WHICH HAVE COMBINED ACTIVITY SERT, 5-HT3 AND 5-HT1A | |
| EA201000702A1 (en) | SOME DERIVATIVES 2-PYRAZINONE AND THEIR APPLICATION AS NEUTROFIL ELASTASIS INHIBITORS | |
| EA200900135A1 (en) | DERIVATIVES OF PYRAZOL AS A CYTOCHROME P450 INHIBITORS | |
| ATE450533T1 (en) | CARBOXAMIDE DERIVATIVES | |
| ES2422557T3 (en) | Compounds and compositions as modulators of the Hedgehog route | |
| ECSP088296A (en) | THERAPEUTIC COMPOUNDS | |
| UY30316A1 (en) | SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS | |
| ECSP088457A (en) | USEFUL BENZAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETILASE | |
| ECSP099442A (en) | DERIVATIVES OF HETEROARIL-PIRROLIDINIL- AND -PIPERIDINIL-CETONA | |
| BRPI0415053B8 (en) | p-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| ES2546847T3 (en) | Formulations of a Src / Abl inhibitor | |
| EP1714961A4 (en) | INDAZOLE COMPOSITION AND PHARMACEUTICAL USE THEREOF | |
| SE0302546D0 (en) | New compounds | |
| UY29234A1 (en) | ADAMANTAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, BOTH PREPARATION PROCEDURES AND APPLICATIONS. | |
| SE0301701D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| BRPI0615158A8 (en) | compound, pharmaceutical composition, and methods for treating or preventing a disease or condition, and for preparing a compound. | |
| SE0301699D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| CR8748A (en) | AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITION | |
| WO2008004100A9 (en) | Therapeutic compounds | |
| CU20060213A7 (en) | AN ANTIMICOBACTERIAL PHARMACEUTICAL COMPOSITION | |
| CR8955A (en) | HEXADECASACARIDOS BIOTINILADOS, ITS PREPARATION AND ITS USE | |
| SE0402763D0 (en) | Nitro indazole derivatives | |
| UA95250C2 (en) | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp4503a4) |